Biorestorative Therapies Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 25.41, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Biorestorative Therapies Inc in Mar 31 2026 quarter, has decreased to 14 days, compared to 17 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 466 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 445 to 3034.

What is Receivable Turnover Ratio?
What is Biorestorative Therapies Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BRTX Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-46.8 %	-91.77 %	-91.88 %	-45.26 %	-28.57 %
Y / Y Revenue Change	14.6 %	-54.73 %	-94.95 %	240.4 %	-28.57 %
Receivable Turnover Ratio (TTM)	25.41	20.88	6.34	6.15	3.85
BRTX's Total Ranking	# 3034	# 445	# 3335	# 2728	# 3469
Accounts Receivable average collection period days	14	17	58	59	95
Seq. Receivable Change	-14.19 %	15.67 %	-10.67 %	-40 %	-86.73 %
Seq. Revenue Change	46.17 %	66.1 %	-96.11 %	1113.2 %	-42.26 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 41
Healthcare Sector	# 467
Overall Market	# 3034

Receivable Turnover Ratio Statistics
High	Average	Low
0.38	0.08	0
(Mar 31 2015)		(Mar 31 2014)

BRTX Company Profile • Back to BRTX Efficiency Comparisons • Compare BRTX Receivables Turnover Ratio to its Competitors

Financial Statements
Biorestorative Therapies Inc 's Accounts Receivable	$ 0 Millions	Visit BRTX's Balance sheet
Biorestorative Therapies Inc 's Sales TTM	$ 0 Millions	Visit BRTX's Income Statement
Sources of BRTX's Revenues		Visit BRTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BRTX's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BRTX's Growth Rates	BRTX's Roa	BRTX's Inventory Turnover Ratio	BRTX's Dividend Comparisons
BRTX's Profitability Ratios	BRTX's Roi	BRTX's Asset Turnover Ratio	BRTX's Dividend Growth
BRTX's Valuation Ratios	BRTX's Roe	BRTX's Financial Strength Ratios	BRTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Caribou Biosciences Inc	73.58	$ 11.203 Millions	$ 0.152 Millions
Lifevantage Corp	67.74	$ 193.618 Millions	$ 2.858 Millions
Sangamo Therapeutics Inc	64.62	$ 34.557 Millions	$ 0.535 Millions
Hims and Hers Health Inc	63.35	$ 2,369.476 Millions	$ 37.405 Millions
Humacyte Inc	58.59	$ 34.376 Millions	$ 0.587 Millions
Aim Immunotech Inc	53.71	$ 0.094 Millions	$ 0.002 Millions
Agenus Inc	51.40	$ 123.866 Millions	$ 2.410 Millions
Brookdale Senior Living Inc	49.21	$ 3,145.058 Millions	$ 63.914 Millions
Precision Biosciences Inc	45.03	$ 45.073 Millions	$ 1.001 Millions
Fortrea Holdings Inc	44.31	$ 2,708.600 Millions	$ 61.125 Millions
National Vision Holdings Inc	41.80	$ 2,021.044 Millions	$ 48.351 Millions
Metagenomi Therapeutics Inc	41.78	$ 22.331 Millions	$ 0.535 Millions
Nature s Sunshine Products inc	39.69	$ 489.104 Millions	$ 12.324 Millions
Vireo Growth Inc.	39.45	$ 350.469 Millions	$ 8.884 Millions
Innovage Holding Corp	34.69	$ 949.172 Millions	$ 27.358 Millions
Innovative Eyewear Inc	33.59	$ 2.981 Millions	$ 0.089 Millions
Electrocore Inc	32.90	$ 34.458 Millions	$ 1.047 Millions
U S Physical Therapy Inc	30.94	$ 795.488 Millions	$ 25.708 Millions
Silence Therapeutics Plc	29.70	$ 0.839 Millions	$ 0.028 Millions
Invo Fertility Inc	29.40	$ 7.219 Millions	$ 0.246 Millions
Marpai Inc	29.03	$ 17.125 Millions	$ 0.590 Millions
Lineage Cell Therapeutics Inc	28.42	$ 14.779 Millions	$ 0.520 Millions
Jaguar Health Inc	28.17	$ 29.569 Millions	$ 1.050 Millions
Meiragtx Holdings Plc	28.01	$ 79.758 Millions	$ 2.848 Millions
Cv Sciences Inc	27.37	$ 11.925 Millions	$ 0.436 Millions
Wave Life Sciences Ltd	27.36	$ 88.173 Millions	$ 3.223 Millions
Safe Pro Group Inc	27.29	$ 1.642 Millions	$ 0.060 Millions
Atara Biotherapeutics Inc	27.03	$ 23.540 Millions	$ 0.871 Millions
Biorestorative Therapies Inc	25.41	$ 0.363 Millions	$ 0.014 Millions
Kiniksa Pharmaceuticals International Plc	24.63	$ 754.045 Millions	$ 30.618 Millions

Date modified: 2026-09-08T17:44:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.